NCT00002314View on ClinicalTrials.gov

A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Sarcoma, KaposiHIV Infections

Interventions

DRUG

Ro 24-7429

Trial Locations (2)

900951793

CARE Ctr / UCLA Med Ctr, Los Angeles

02215

New England Deaconess Hosp, Boston

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00002314 - A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter